The Idea (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: a Prospective Pooled Non-Inferiority Analysis of > 11,500 Patients from 6 Phase III Trials of Adjuvant Therapy Duration with Folfox (Folfox4 or Mfolfox6) or Xelox (3 Vs. 6 Months) for Stage III Colon Cancer
Year: 2014
Type: article
Source: Annals of Oncology
Institutions: Mayo Clinic, University of Glasgow, Ospedale Policlinico San Martino, Hôpital Saint-Antoine, Wayne State University, The Barbara Ann Karmanos Cancer Institute, National Cancer Center Hospital East, University of Crete, Southampton General Hospital, Hôpital Européen Georges-Pompidou, Dana-Farber Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2374617617